A group of eight past chairs of the MD Anderson Cancer Center Faculty Senate have weighed into the controversy over leadership and morale at the Houston-based hospital.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
